이상반응 보고
| VAERS ID | 1628273 |
|---|---|
| 성별 | 여성 |
| 나이 | 32세 |
| 주 코드 | NC |
| 제약회사 | MODERNA |
| 로트 번호 | 012M20A |
| 예방접종 횟수 | 1 |
| 접종일 | 2021-02-27 |
| 발병일 | 2021-08-03 |
| 상태 | 입원 회복 |
증상
- C 반응성 단백질 증가(C-reactive protein increased)
- 적혈구 침강 속도 증가(Red blood cell sedimentation rate increased)
- 뇌 나트륨 이뇨 펩티드 증가(Brain natriuretic peptide increased)
- 트로포닌 증가(Troponin increased)
- 심장 기능 검사 정상(Cardiac function test normal)
- 사출 비율 정상(Ejection fraction normal)
- 심근염(Myocarditis)
이환 중 질병
n/a
지병
+ANA, PCOS, obesity, iron deficiency anemia, hypothyroidism, bilateral knee OA, anxiety, insomnia, chronic joint pain
기타 의료
cetirizine 10 mg oral tablet, 1 tablet, ORAL, qHS (each night at bedtime) clonazePAM 1 mg oral tablet, 1 tablet, ORAL, BID (2 times a day), PRN, 2 refills Complete Natal DHA oral kit, See Instructions DULoxetine 60 mg oral delayed release c
이전 예방접종
알레르기
sulfa drugs
임상 검사
Acute myocarditis onset 8/3/21 requiring hospitalization for 1 day.
Elevated troponin, sedimentation rate, C-RP, and BNP.
Normal LVEF and cardiac function.
Evaluated by cardiology.
Started on beta blocker.
Resolved w/o residual sequalae.
증상 상세
Acute myocarditis onset 8/3/21 requiring hospitalization for 1 day.
Elevated troponin, sedimentation rate, C-RP, and BNP.
Normal LVEF and cardiac function.
Evaluated by cardiology.
Started on beta blocker.
Resolved w/o residual sequalae.